NO20030523D0 - Polymorphs of zaleplon and processes for their preparation - Google Patents

Polymorphs of zaleplon and processes for their preparation

Info

Publication number
NO20030523D0
NO20030523D0 NO20030523A NO20030523A NO20030523D0 NO 20030523 D0 NO20030523 D0 NO 20030523D0 NO 20030523 A NO20030523 A NO 20030523A NO 20030523 A NO20030523 A NO 20030523A NO 20030523 D0 NO20030523 D0 NO 20030523D0
Authority
NO
Norway
Prior art keywords
zaleplon
polymorphs
processes
preparation
Prior art date
Application number
NO20030523A
Other languages
Norwegian (no)
Other versions
NO20030523L (en
Inventor
Farhan Aslam
Brett Cowans
Stephen Robert Byrn
G Patrick Stahly
Original Assignee
Meda Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meda Ab filed Critical Meda Ab
Publication of NO20030523D0 publication Critical patent/NO20030523D0/en
Publication of NO20030523L publication Critical patent/NO20030523L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
NO20030523A 2000-08-03 2003-02-03 Polymorphs of zaleplon and processes for their preparation NO20030523L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22278500P 2000-08-03 2000-08-03
PCT/US2001/024510 WO2002012244A2 (en) 2000-08-03 2001-08-02 Polymorphs of zaleplon and methods for the preparation thereof

Publications (2)

Publication Number Publication Date
NO20030523D0 true NO20030523D0 (en) 2003-02-03
NO20030523L NO20030523L (en) 2003-03-11

Family

ID=22833666

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030523A NO20030523L (en) 2000-08-03 2003-02-03 Polymorphs of zaleplon and processes for their preparation

Country Status (18)

Country Link
US (2) US20020072527A1 (en)
EP (1) EP1305315A2 (en)
JP (1) JP2004505979A (en)
KR (2) KR20030036659A (en)
CN (2) CN1847244A (en)
AR (1) AR036324A1 (en)
AU (2) AU2001283119B2 (en)
BR (1) BR0113244A (en)
CA (1) CA2417875C (en)
HU (1) HUP0303055A3 (en)
IL (1) IL154088A0 (en)
MX (1) MXPA03001048A (en)
NO (1) NO20030523L (en)
NZ (1) NZ527455A (en)
PL (1) PL365678A1 (en)
SG (1) SG125971A1 (en)
WO (1) WO2002012244A2 (en)
ZA (1) ZA200300779B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005507858A (en) * 2001-06-12 2005-03-24 ビオガル ジョジセルジャール アール テー. How to produce zaleplon
US20050032818A1 (en) * 2001-06-12 2005-02-10 Entire Interest N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
HUP0402253A3 (en) 2001-08-01 2005-12-28 Teva Gyogyszergyar Zartkoeruee Process for the purification of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)-phenyl]-n-ethylacetamide(zaleplon) and the preparation of its novel crystalline forms and pharmaceutical compositions containing the latters
PL373694A1 (en) * 2002-02-15 2005-09-05 Teva Gyogyszergyar Reszvenytarsasag Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
WO2004035585A1 (en) * 2002-10-16 2004-04-29 Sanmar Speciality Chemicals Limited Synthesis of zaleplon
DE112004001615T5 (en) * 2003-09-04 2006-06-14 Cipla Ltd. Zaleplon synthesis
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
EP2370136A4 (en) * 2008-12-01 2015-12-30 Map Pharmaceuticals Inc Inhalation delivery methods and devices
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN102816163A (en) * 2012-08-20 2012-12-12 四川禾邦阳光制药股份有限公司 New crystal form of zaleplon, and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
KR0167261B1 (en) * 1995-10-19 1999-04-15 문정환 The control circuit for power supply
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
AR029780A1 (en) * 2000-12-13 2003-07-16 Gador Sa IMPROVED PROCEDURE FOR OBTAINING N- [3 (3-CIANO-PIRAZOLO [1,5-A] PIRIMIDIN-7-IL) PHENYL] -N-ETIL-ACETAMIDE
HUP0402253A3 (en) * 2001-08-01 2005-12-28 Teva Gyogyszergyar Zartkoeruee Process for the purification of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)-phenyl]-n-ethylacetamide(zaleplon) and the preparation of its novel crystalline forms and pharmaceutical compositions containing the latters

Also Published As

Publication number Publication date
CN1610682A (en) 2005-04-27
SG125971A1 (en) 2006-10-30
HUP0303055A2 (en) 2004-01-28
US20050176735A1 (en) 2005-08-11
PL365678A1 (en) 2005-01-10
KR20030036659A (en) 2003-05-09
MXPA03001048A (en) 2004-02-26
KR20070086867A (en) 2007-08-27
NZ527455A (en) 2005-07-29
AU8311901A (en) 2002-02-18
WO2002012244A2 (en) 2002-02-14
AR036324A1 (en) 2004-09-01
BR0113244A (en) 2003-07-08
AU2001283119B2 (en) 2007-11-15
HUP0303055A3 (en) 2004-11-29
US20020072527A1 (en) 2002-06-13
CA2417875A1 (en) 2002-02-14
IL154088A0 (en) 2003-07-31
ZA200300779B (en) 2003-08-22
NO20030523L (en) 2003-03-11
EP1305315A2 (en) 2003-05-02
CA2417875C (en) 2008-12-09
WO2002012244A3 (en) 2002-06-13
CN1847244A (en) 2006-10-18
JP2004505979A (en) 2004-02-26

Similar Documents

Publication Publication Date Title
NO20001648D0 (en) Methods and intermediates for the preparation of anti-cancer compounds
NO20030844D0 (en) Process for the preparation of N-aryl-anthranilic acids and derivatives thereof
NO20044533D0 (en) Process for Preparation of 7-Substituted 3-Quinoline and 3-Quinol-4-Oncarbonitriles
NO20030707L (en) Polymorphs of an epothilone analog
CY2013011I1 (en) METHOD OF ADMINISTRATION OF DIPHOSPHONICS
NO20042680L (en) Processes for the preparation of O-demethylvenflaxine
NO20021412L (en) Soy milk mixtures and methods of preparation
NO20022176D0 (en) Absorbent article and process for its preparation
NO20032332L (en) Benzodiazepine derivative compounds, method of preparation and use thereof
NO20015542D0 (en) Process for the preparation and use of N-desmethylzopiclones
NO20011026D0 (en) Foodstuffs and methods of manufacture thereof
DK1328538T3 (en) Process and intermediates for the preparation of 7-substituted antiestrogens
NO20020622L (en) Polymorphs of torsemide
NO20030523D0 (en) Polymorphs of zaleplon and processes for their preparation
NO20021124D0 (en) Process for the preparation of benzoxazine derivatives and intermediates therefore
NO20035538D0 (en) Process for the preparation of zaleplon
NO20040887L (en) Purification and crystalline forms of zaleplon.
NO20003555L (en) Process for the preparation of structural elements and the resulting elements
NO20024413L (en) Process for making and using microgroups of biological materials
NO20030515D0 (en) Process for the preparation of dinapsoline
NO20033743D0 (en) Process and preparation of citalopram
EE200200410A (en) Process for the Preparation of Acetylamidinophenylalanylcyclohexylglycylpyridinylalaninamides and Starting and Intermediate Compounds
NO20023702L (en) Process for the preparation of 5-arylnicotinaldehydes
NO20035668D0 (en) Anti-tumor formulations of thioxanthenone
EE200200053A (en) Process of preparation of isoretinoin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application